£890.00

It has never been this cheap. We have no record of a lower price.

£890 today · cheaper than every other day in the last 3 months

The 2027-2032 World Outlook for Glaucoma Pharmaceuticals

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days · 61 data points (no recent data)

Historical
Generating forecast…
£890.00 £845.50 £863.30 £881.10 £898.90 £916.70 £934.50 22 August 2026 06 September 2026 21 September 2026 06 October 2026 21 October 2026
View at Amazon ↗

Price data last checked 30 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 61 days • 1 price levels

Days at Price
61 days 0 15 31 46 61 £890 Days at Price

Price Analysis

Most common price: £890 (61 days, 100.0%)

Price range: £890 - £890

Price levels: 1 different prices over 61 days

Description

This study covers the world outlook for glaucoma pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of glaucoma pharmaceuticals as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Acadia Pharmaceuticals, Alcon Laboratories, Allergan, Falcon Pharmaceuticals, and Inotek Pharmaceuticals Corporation. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2026).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
05 January 2026
Listed Since
10 February 2026

Similar Products You Might Like

The 2027-2032 World Outlook for Optic Nerve Disorders Treatments
95% match

The 2027-2032 World Outlook for Optic Nerve Disorders Treatments

£890.00 21 Sep 2026
The 2027-2032 World Outlook for Nocturia Drugs
95% match

The 2027-2032 World Outlook for Nocturia Drugs

£890.00 22 Oct 2026
The 2027-2032 World Outlook for Cholestrol Lowering Drugs
94% match

The 2027-2032 World Outlook for Cholestrol Lowering Drugs

£890.00 24 Oct 2026
The 2027-2032 World Outlook for Antidotes
94% match

The 2027-2032 World Outlook for Antidotes

£890.00 16 Sep 2026
The 2027-2032 World Outlook for HIV Therapeutics
94% match

The 2027-2032 World Outlook for HIV Therapeutics

£890.00 16 Oct 2026
The 2027-2032 World Outlook for Speciality Fertilizers
94% match

The 2027-2032 World Outlook for Speciality Fertilizers

£890.00 26 Oct 2026
The 2027-2032 World Outlook for Drugs for Rheumatoid Arthritis
94% match

The 2027-2032 World Outlook for Drugs for Rheumatoid Arthritis

£890.00 30 Oct 2026
The 2027-2032 World Outlook for Interventional Radiology Products
94% match

The 2027-2032 World Outlook for Interventional Radiology Products

£890.00 10 Sep 2026
The 2027-2032 World Outlook for Magnesium Glycinates
94% match

The 2027-2032 World Outlook for Magnesium Glycinates

£890.00 21 Oct 2026
The 2027-2032 World Outlook for Butanes
94% match

The 2027-2032 World Outlook for Butanes

£890.00 22 Oct 2026
The 2027-2032 World Outlook for Chronic Obstructive Pulmonary Disease Treatments
94% match

The 2027-2032 World Outlook for Chronic Obstructive Pulmonary Disease Treatments

£890.00 16 Oct 2026
The 2027-2032 World Outlook for Topical Vitiligo Therapeutics
94% match

The 2027-2032 World Outlook for Topical Vitiligo Therapeutics

£890.00 29 Oct 2026
The 2027-2032 World Outlook for Cardiac Rhythm Management
93% match

The 2027-2032 World Outlook for Cardiac Rhythm Management

£890.00 27 Oct 2026
The 2027-2032 World Outlook for Mixed Nocturia
93% match

The 2027-2032 World Outlook for Mixed Nocturia

£890.00 22 Oct 2026
The 2027-2032 World Outlook for Urea Formaldehydes
93% match

The 2027-2032 World Outlook for Urea Formaldehydes

£890.00 12 Nov 2026
The 2027-2032 World Outlook for Speciality Solvents
93% match

The 2027-2032 World Outlook for Speciality Solvents

£890.00 26 Oct 2026
The 2027-2032 World Outlook for Interventional Radiology Systems
93% match

The 2027-2032 World Outlook for Interventional Radiology Systems

£890.00 08 Sep 2026
The 2027-2032 World Outlook for Mica
93% match

The 2027-2032 World Outlook for Mica

£890.00 17 Sep 2026
The 2027-2032 World Outlook for Menopausal Hot Flashes Therapies
93% match

The 2027-2032 World Outlook for Menopausal Hot Flashes Therapies

£890.00 27 Oct 2026
The 2027-2032 World Outlook for Molecular Sieves
93% match

The 2027-2032 World Outlook for Molecular Sieves

£890.00 22 Oct 2026
The 2027-2032 World Outlook for Formaldehydes
93% match

The 2027-2032 World Outlook for Formaldehydes

£890.00 09 Sep 2026
The 2027-2032 World Outlook for Medical Exoskeletons
93% match

The 2027-2032 World Outlook for Medical Exoskeletons

£890.00 24 Oct 2026
The 2027-2032 World Outlook for Carboxy Methyl Cellulose
93% match

The 2027-2032 World Outlook for Carboxy Methyl Cellulose

£890.00 04 Nov 2026
The 2027-2032 World Outlook for Dentures
93% match

The 2027-2032 World Outlook for Dentures

£890.00 10 Nov 2026